Gainers
- Immutep (NASDAQ:IMMP) stock rose 18.1% to $3.39 during Wednesday's after-market session. Today's trading volume for this security ended up closing at 58.5K shares, which is 30.9 percent of its average volume over the last 100 days. The company's market cap stands at $289.5 million.
- iSpecimen (NASDAQ:ISPC) stock moved upwards by 9.15% to $4.65. The company's market cap stands at $40.6 million.
- Salarius Pharmaceuticals (NASDAQ:SLRX) shares moved upwards by 8.99% to $0.41. Today's trading volume for this security ended up closing at 109.4K shares, which is 32.6 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $18.4 million.
- Bone Biologics (NASDAQ:BBLG) stock increased by 7.21% to $2.08. The market value of their outstanding shares is at $21.5 million.
- Lucira Health (NASDAQ:LHDX) stock moved upwards by 5.39% to $3.71. The company's market cap stands at $145.5 million.
- Indaptus Therapeutics (NASDAQ:INDP) shares rose 5.04% to $4.04. The market value of their outstanding shares is at $33.1 million.
Losers
- NexImmune (NASDAQ:NEXI) shares fell 8.3% to $2.11 during Wednesday's after-market session. The company's market cap stands at $47.9 million.
- Revelation Biosciences (NASDAQ:REVB) shares fell 7.06% to $1.58. This security traded at a volume of 325.5K shares come close, making up 22.7% of its average volume over the last 100 days. The company's market cap stands at $22.4 million.
- CohBar (NASDAQ:CWBR) shares decreased by 6.95% to $0.26. The company's market cap stands at $22.3 million.
- OpGen (NASDAQ:OPGN) shares fell 4.7% to $0.81. The market value of their outstanding shares is at $37.6 million.
- Statera BioPharma (NASDAQ:STAB) shares declined by 4.34% to $0.66. This security traded at a volume of 378.1K shares come close, making up 67.0% of its average volume over the last 100 days. The market value of their outstanding shares is at $23.7 million.
- Novan (NASDAQ:NOVN) stock declined by 4.33% to $3.32. The company's market cap stands at $62.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
